Literature DB >> 3582717

Collagen synthesis in the vaginal connective tissue of patients with and without uterine prolapse.

J Mäkinen, V M Kähäri, K O Söderström, E Vuorio, T Hirvonen.   

Abstract

The insufficiency of connective tissue in pelvic relaxation was studied in five patients with uterine descent and in five age-related controls. Samples from vaginal fascias were first studied by histology. Fibroblast cultures started from each sample were analysed for their collagen synthesis and content of type I procollagen messenger RNAs (mRNAs). The cellularity of the fascias in histological specimens and the biosynthesis of collagen in fibroblast cultures decreased with increasing age in both groups. Fibroblasts grown from patients with uterine descent exhibited rates of collagen synthesis similar to or slightly higher than those from age-matched controls. The histological and biochemical changes observed in connective tissue of uterine descent are most likely related to the age and hormonal status of the patients. The findings suggest that uterine descent is not related to defects in the capacity of vaginal fibroblasts to synthesize or process procollagen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3582717     DOI: 10.1016/0028-2243(87)90157-2

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  13 in total

Review 1.  Changes in connective tissue in patients with pelvic organ prolapse--a review of the current literature.

Authors:  M H Kerkhof; L Hendriks; H A M Brölmann
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-10-15

2.  Expression of matrix metalloproteinase-1 in round ligament and uterosacral ligament tissue from women with pelvic organ prolapse.

Authors:  Akın Usta; Kadir Guzin; Mehmet Kanter; Mustafa Ozgül; Ceyda Sancaklı Usta
Journal:  J Mol Histol       Date:  2013-11-08       Impact factor: 2.611

3.  Light and electron microscopic evaluation of cardinal ligaments in women with or without uterine prolapse.

Authors:  Mehmet Coskun Salman; Ozgur Ozyuncu; Mustafa Fevzi Sargon; Turkan Kucukali; Tekin Durukan
Journal:  Int Urogynecol J       Date:  2009-10-01       Impact factor: 2.894

4.  Is anatomical failure following anterior vaginal repair associated with weak native vaginal tissues? A biomechanical and immunohistochemical study.

Authors:  A Khaja; P Winlove; M Waterfield; A Oriolowo; O A Adekanmi; R M Freeman
Journal:  Int Urogynecol J       Date:  2013-10-15       Impact factor: 2.894

5.  Increased expression of matrix metalloproteinase 2 in uterosacral ligaments is associated with pelvic organ prolapse.

Authors:  Boris Gabriel; Dirk Watermann; Katharina Hancke; Gerald Gitsch; Martin Werner; Clemens Tempfer; Axel zur Hausen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-12-08

6.  Rectus fascia colpopexy in posthysterectomy vaginal prolapse: analysis of 18 cases.

Authors:  M J Girão; V M Wakavaiach; M G Sartori; E C Baracat; G R de Lima
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

7.  Tissue-engineered fascia from vaginal fibroblasts for patients needing reconstructive pelvic surgery.

Authors:  Man-Jung Hung; Mei-Chin Wen; Chia-Nung Hung; Esther Shih-Chu Ho; Gin-Den Chen; Vivian Cheng Yang
Journal:  Int Urogynecol J       Date:  2010-05-18       Impact factor: 2.894

8.  Decreased type III collagen expression in human uterine cervix of prolapse uteri.

Authors:  Masaaki Iwahashi; Yasuteru Muragaki
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

9.  Changes in the extracellular matrix in the anterior vagina of women with or without prolapse.

Authors:  Sheng-Yen Lin; Yi-Torng Tee; Soo-Cheen Ng; Han Chang; PinPin Lin; Gin-Den Chen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-03-18

10.  Diminished vaginal HOXA13 expression in women with pelvic organ prolapse.

Authors:  Kathleen A Connell; Marsha K Guess; Alison Tate; Vaagn Andikyan; Richard Bercik; Hugh S Taylor
Journal:  Menopause       Date:  2009 May-Jun       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.